Medicare clozapine data analysis.

Slični predmeti

• National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020.
  od: Luke R. Cavanah (19022435)
  Izdano: (2025)
• Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9), which is denoted by the dotted line. ^b indicates ≥1.96 SD from the mean.
  od: Luke R. Cavanah (19022435)
  Izdano: (2025)
• Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0), which is denoted by the dotted line. ^b indicates ≥1.96 SD from the mean.
  od: Luke R. Cavanah (19022435)
  Izdano: (2025)
• Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9), which is denoted by the dotted line. ^b indicates ≥1.96 SD from the mean.
  od: Luke R. Cavanah (19022435)
  Izdano: (2025)
• Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1), which is denoted by the dotted line. ^b indicates ≥1.96 SD from the mean.
  od: Luke R. Cavanah (19022435)
  Izdano: (2025)